Skip to main content
Fig. 4 | BMC Biomedical Engineering

Fig. 4

From: A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration

Fig. 4

Sagittal section of MINIject in ocular tissues stained with hematoxylin & eosin, 1 month (a, c and f), 3 months (d and g), or 6 months (b, e and h) after implantation in the suprachoroidal space of Dutch Belted rabbits. MINIject is delineated with dotted lines. 1., Magnification in panel f; 2., Magnification in panel c; 3., Magnification in panel h; 4., Magnification in panel e; *, neovessels. Scale of 1 mm shown in (a and b). Scale of 50 μm shown in (c, d, e, f, g, h)

Back to article page